Redox and Google Cloud Partner to Accelerate Healthcare Data Interoperability

Redox, a leader in healthcare interoperability, and Google Cloud today announced a partnership to simplify the exchange of healthcare data so organizations can make better and faster decisions. By easily onboarding health data from legacy systems into Google Cloud products like Healthcare Data Engine and Healthcare API, organizations can build longitudinal views to better serve their patients and members. As a part of the partnership, Redox will replicate its platform on Google Cloud, offering Google Cloud customers the full range of Redox’s world-class products, services, and experiences.

The information healthcare leaders and administrators need is often siloed across multiple IT systems and organizations. In addition, it is difficult to access, often taking years to exact and normalize. It may be buried deep in the patient record or spread across databases that don’t speak to each other. Improving the flow and unification of data across health care systems, referred to as interoperability, is critical to helping organizations run more effectively, improving patient care and enabling people to live healthier lives. There is a growing body of regulatory requirements in the U.S. that reinforce interoperability of patient data as a priority for providers and health plans. The Office of the National Coordinator for Health Information Technology (ONC) Cures Act Final Rule requires that patients have secure access to their electronic health information to use and share, and the Centers for Medicare and Medicaid Services (CMS) Interoperability and Patient Access Rule requires that health plans participating in federal exchanges share claims data with patients electronically.

“Healthcare organizations are transforming using new applications and analytics tools driven by cloud technology. Redox was designed to support these new tools with enterprise-scale data exchange with hospitals, clinics, health plans, Healthcare Information Exchanges, networks and other sources that provide the foundation of healthcare data,” said Redox CEO Luke Bonney. “Together, Redox and Google Cloud enable providers and health plans to maximize the use of their legacy system data in a single cloud database up to 80% faster than other solutions.”

With Redox Healthcare Integration, now available on Google Cloud Marketplace, health plans, providers, life science, medical device companies, and digital health organizations can incorporate standards like HL7v2, C-CDA, X12, DICOM, and more into FHIR, leveraging existing provider integrations and libraries. This makes it faster and easier for organizations to use Google Cloud’s Healthcare API and Healthcare Data Engine, enabling an interoperable, longitudinal record of patient data.

“When we first collaborated with Redox and saw how fast we could help a healthcare organization further accelerate data interoperability, we had an ‘aha’ moment,” said Chris Sakalosky, vice president, Strategic Industries at Google Cloud. “With this partnership, we continue to help organizations across the healthcare spectrum tackle the most complex data harmonization challenges, unlocking insights and improving outcomes.”

For more information, learn how Redox works with Google Cloud, and check out the Redox Healthcare Integration listing on Google Cloud Marketplace.

Privacy and security
Privacy and security are of the utmost importance in all aspects of Google Cloud’s products. Through the implementation of Google Cloud’s reliable infrastructure and secure data storage that support HIPAA compliance—along with each customer’s layers of security, privacy controls and processes—customers are able to protect the access and use of patient data.

About Redox
Payers, providers, and digital health companies use Redox to produce differentiated experiences for patients and clinicians. Connecting to more than 4,500 healthcare organizations, Redox provides a composable software experience across the healthcare ecosystem. With our single API, product teams are empowered to build whatever they can imagine. Redox accelerates innovations that make healthcare data more useful than ever before. For more information, visit www.redoxengine.com.

About Google Cloud
Google Cloud accelerates every organizations’ ability to digitally transform its business. We deliver enterprise-grade solutions that leverage Google’s cutting-edge technology – all on the cleanest cloud in the industry. Customers in more than 200 countries and territories turn to Google Cloud as their trusted partner to enable growth and solve their most critical business problems.

FHIR is a registered trademark of Health Level Seven International (HL7) and is used with the permission of HL7. Use of this trademark does not constitute an endorsement of products/services by HL7.

 

Source Link

Recommended Articles

New NFIB Survey: Small Businesses Report Reduced Optimism

The NFIB Small Business Optimism Index fell 0.6 points in May to 95.3, remaining below its 52-year average of 98.0. The Uncertainty Index rose 3 points from April to 91, remaining well above its historical average of 68. As reported in NFIB’s monthly Jobs Report, the NFIB Small Business Employment Index remained essentially flat, registering 100.3 in May. ...

Read More

Trump Announces TrumpRx Expansion, Adding 160 More Drugs

President Trump on Friday announced that over 100 prescription medications would be added to his administration’s direct-to-consumer drug platform, TrumpRx, the second expansion of the initiative in as many months. “I am pleased to announce that TrumpRx.gov is adding another 160 Prescription Drugs, at highly discounted prices, for a new total of over 800 of the most commonly-used Prescription Drugs,” ...

Read More

Skyrocketing GLP-1 Demand Creates Major Financial Strain For Employers

GLP-1 drugs are a double-edged sword for the nation’s employers. Although they are having a demonstrable effect on workplace health, the high cost is putting a strain on their budgets. GLP-1s, known by brand names such as Ozempic, Wegovy, Mounjaro or Zepbound, originally were developed to help regulate blood sugar in people with Type 2 ...

Read More

Judge Throws Out Policy Imposing $100,000 Fees for Skilled Worker Visas

A Trump administration initiative to impose $100,000 fees on employers seeking visas for skilled foreign workers amounts to an unlawful tax on those companies and must be voided “in its entirety,” a federal judge ruled on Monday. The decision by Judge Leo T. Sorokin of the Federal District Court for the District of Massachusetts nullified ...

Read More
arrowcaret-downclosefacebook-squarehamburgerinstagram-squarelinkedin-squarepauseplaytwitter-squareyoutube-square